tiprankstipranks
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market

Protagonist Therapeutics (PTGX) Income Statement

Compare
633 Followers

Protagonist Therapeutics Income Statement

Last quarter (Q3 2024), Protagonist Therapeutics's total revenue was $4.67M, an increase of Infinity% from the same quarter last year. In Q3, Protagonist Therapeutics's net income was $-33.21M. See Protagonist Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 60.00M$ 26.58M$ 27.36M$ 28.63M
Gross Profit
$ 0.00$ 60.00M$ 25.55M$ 24.58M$ 28.63M
Operating Expenses
$ 181.59M$ 153.65M$ 157.95M$ 153.20M$ 93.14M
Depreciation and Amortization
$ 0.00$ 3.31M$ 1.03M$ 2.77M$ 789.00K
EBITDA
$ 252.84M$ -90.34M$ -131.37M$ -123.07M$ -63.66M
Operating Income
$ 252.84M$ -93.65M$ -131.37M$ -125.84M$ -64.52M
Other Income/Expenses
$ 26.57M$ 14.70M$ 3.98M$ 294.00K$ -329.00K
Pretax Income
$ 279.41M$ -78.95M$ -127.39M$ -125.55M$ -64.84M
Net Income
$ 275.19M$ -78.95M$ -123.41M$ -122.63M$ -66.15M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 4.47$ -1.39$ -2.52$ -2.65$ -1.92
Diluted EPS
$ 4.23$ -1.39$ -2.52$ -2.65$ -1.92
Weighted Average Shares Outstanding
61.57M 56.76M 49.04M 46.32M 34.40M
Weighted Average Shares Outstanding (Diluted)
65.08M 56.76M 49.04M 46.32M 34.40M
Currency in USD

Protagonist Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis